REGENXBIO Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	58.8	57.53	34.52	96.95	345.21	338.43
Short-Term Investments	215.4	177.16	240.74	267.69	112.23	137.31
Cash & Short-Term Investments	274.21	234.69	275.26	364.64	457.44	475.74
Cash Growth	7.34%	-14.74%	-24.51%	-20.29%	-3.85%	60.61%
Accounts Receivable	25.35	20.47	24.79	28.08	28.51	43.35
Other Receivables	18.15	12.4	19.3	8.5	-	-
Receivables	43.5	32.87	44.09	36.59	28.51	43.35
Prepaid Expenses	12.94	9.07	14.52	13.9	18.75	10.51
Other Current Assets	1.32	1.38	1.11	0.85	14.12	1.6
Total Current Assets	331.97	278	334.97	415.98	518.83	531.2
Property, Plant & Equipment	156.34	171.31	192.59	206.8	192.45	120.28
Long-Term Investments	27.84	10.18	38.87	200.56	391.91	47.91
Long-Term Accounts Receivable	2.77	0.47	0.7	1.5	2.26	3.27
Other Long-Term Assets	6.3	6.03	6.84	8.43	8.46	5.51
Total Assets	525.2	465.99	573.97	833.27	1,114	708.16
Accounts Payable	22.27	22.8	22.79	27.21	11.39	10.62
Accrued Expenses	38.24	37.91	49.32	45.99	59.5	38.09
Current Portion of Long-Term Debt	41.72	34.31	50.57	48.6	37.89	18.79
Current Portion of Leases	9.07	7.9	7.07	6	1.75	2.5
Current Income Taxes Payable	-	-	-	-	11.33	3.14
Current Unearned Revenue	13.2	0.12	0.15	1.83	3.33	0.45
Other Current Liabilities	0.08	0.16	0.39	0.81	5.29	7.85
Total Current Liabilities	124.57	103.19	130.27	130.43	130.47	81.45
Long-Term Debt	149.92	25.38	43.49	89.01	133.46	174.5
Long-Term Leases	67.43	74.13	82.22	88.8	84.93	70.15
Long-Term Unearned Revenue	21.19	-	-	-	-	3.78
Other Long-Term Liabilities	0.65	3.64	6.25	8.83	0.75	0.52
Total Liabilities	363.75	206.34	262.23	317.07	349.61	330.41
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	1,221	1,193	1,021	973.15	928.1	667.18
Retained Earnings	-1,059	-932.15	-705.05	-441.55	-161.23	-289.07
Comprehensive Income & Other	-0.65	-0.74	-4.43	-15.4	-2.57	-0.36
Total Common Equity	161.45	259.65	311.74	516.2	764.3	377.75
Shareholders' Equity	161.45	259.65	311.74	516.2	764.3	377.75
Total Liabilities & Equity	525.2	465.99	573.97	833.27	1,114	708.16
Total Debt	268.14	141.72	183.34	232.41	258.03	265.95
Net Cash (Debt)	33.9	103.15	130.79	332.8	591.32	256.6
Net Cash Growth	-74.46%	-21.13%	-60.70%	-43.72%	130.45%	-33.99%
Net Cash Per Share	0.66	2.08	2.99	7.71	13.47	6.88
Filing Date Shares Outstanding	50.62	50.09	44.43	43.46	42.95	42.5
Total Common Shares Outstanding	50.62	49.55	44.05	43.3	42.83	37.48
Working Capital	207.4	174.81	204.7	285.54	388.35	449.75
Book Value Per Share	3.19	5.24	7.08	11.92	17.84	10.08
Tangible Book Value	161.45	259.65	311.74	516.2	764.3	377.75
Tangible Book Value Per Share	3.19	5.24	7.08	11.92	17.84	10.08
Machinery	89.52	88.42	87.38	83.68	68.05	34.18
Leasehold Improvements	101.53	101.47	101.93	99.4	92.54	44.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.